Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced
225Ac
Actinium-225
Chelating ligands
ISAC ISOL
Isotope separation on-line
Radiolabeling
Radionuclide production
Targeted alpha therapy
α-Melanocyte-stimulating hormone
Journal
EJNMMI radiopharmacy and chemistry
ISSN: 2365-421X
Titre abrégé: EJNMMI Radiopharm Chem
Pays: England
ID NLM: 101714628
Informations de publication
Date de publication:
06 Aug 2019
06 Aug 2019
Historique:
received:
30
04
2019
accepted:
18
07
2019
entrez:
30
10
2019
pubmed:
30
10
2019
medline:
30
10
2019
Statut:
epublish
Résumé
Actinium-225 ( MBq quantities of TRIUMF's ISOL facility is able to provide
Sections du résumé
BACKGROUND
BACKGROUND
Actinium-225 (
RESULTS
RESULTS
MBq quantities of
CONCLUSION
CONCLUSIONS
TRIUMF's ISOL facility is able to provide
Identifiants
pubmed: 31659557
doi: 10.1186/s41181-019-0072-5
pii: 10.1186/s41181-019-0072-5
pmc: PMC6684685
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21Subventions
Organisme : NSERC Discovery
ID : 00
Organisme : National Research Council of Canada
ID : n/a
Références
Tumour Biol. 2012 Jun;33(3):573-90
pubmed: 22143940
ACS Cent Sci. 2017 Mar 22;3(3):176-185
pubmed: 28386595
Curr Radiopharm. 2018;11(3):200-208
pubmed: 29732998
Theranostics. 2017 Feb 8;7(4):805-813
pubmed: 28382155
Angew Chem Int Ed Engl. 2017 Nov 13;56(46):14712-14717
pubmed: 28963750
J Chromatogr A. 2015 Feb 6;1380:55-63
pubmed: 25596759
Clin Cancer Res. 2008 Jun 1;14(11):3555-61
pubmed: 18519789
Dalton Trans. 2014 Jan 7;43(1):119-31
pubmed: 24104523
Appl Radiat Isot. 2002 Dec;57(6):841-7
pubmed: 12406626
J Nucl Med. 2018 Jun;59(6):878-884
pubmed: 29545378
Front Oncol. 2014 Jan 14;3:324
pubmed: 24459634
Appl Radiat Isot. 2017 Apr;122:222-228
pubmed: 28189025
J Am Chem Soc. 2013 Aug 28;135(34):12707-21
pubmed: 23901833
Chemistry. 2017 Nov 13;23(63):15945-15956
pubmed: 28815804
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):129-138
pubmed: 30232539
Anal Chem. 2005 Oct 1;77(19):6288-91
pubmed: 16194090
Bioconjug Chem. 2000 Jul-Aug;11(4):510-9
pubmed: 10898572
Nucl Med Biol. 2013 Jul;40(5):592-9
pubmed: 23602604
Curr Radiopharm. 2018;11(3):156-172
pubmed: 29658444
J Nucl Med. 2014 Sep;55(9):1492-8
pubmed: 24982438
Nat Commun. 2016 Aug 17;7:12312
pubmed: 27531582
Curr Radiopharm. 2018;11(3):173-179
pubmed: 29669509
J Nucl Med. 2018 Jul;59(7):1020-1027
pubmed: 29496984
EJNMMI Radiopharm Chem. 2017;1(1):6
pubmed: 29564383
Biopolymers. 2010;94(6):820-9
pubmed: 20564045
Phys Med Biol. 2018 Feb 21;63(4):045025
pubmed: 29466250
Chem Commun (Camb). 2018 Mar 8;54(21):2599-2602
pubmed: 29388990
J Nucl Med. 2018 May;59(5):795-802
pubmed: 29326358
J Am Chem Soc. 2012 May 23;134(20):8670-83
pubmed: 22540281
PLoS One. 2014 Feb 07;9(2):e88239
pubmed: 24516620
J Nucl Med. 2016 Dec;57(12):1941-1944
pubmed: 27390158
Inorg Chem. 2015 Feb 16;54(4):2017-31
pubmed: 25621728
Chem Soc Rev. 2014 Jan 7;43(1):260-90
pubmed: 24173525
Bioconjug Chem. 2017 Aug 16;28(8):2145-2159
pubmed: 28683198
Nucl Med Biol. 2017 May;48:31-35
pubmed: 28193502
J Med Chem. 1999 Jul 29;42(15):2988-92
pubmed: 10425108
J Med Chem. 2014 Jun 12;57(11):4849-60
pubmed: 24814511
Chem Commun (Camb). 2013 May 25;49(42):4720-39
pubmed: 23599005
Immunotherapy. 2014;6(4):431-58
pubmed: 24815783